Jagsonpal PharmaceuticalsJAGSNPHARM 
$4.78-2.58%24h
-2.58%24h
Global rank20036
Market cap$125.13M
Change 7d5.53%
YTD Performance2.44%
SP500 benchmarkUnderperform
P/E0.47
P/S4.43
Revenue$28.22M
Earnings$3.19M
Dividend yield-
Main Sector
Healthcare
Category
Jagsonpal Pharmaceuticals (JAGSNPHARM) Total Liabilities
JAGSNPHARM Total Liabilities in 2022: $4.30M
According to Jagsonpal Pharmaceuticals latest financial reports the total liabilities of JAGSNPHARM is $4.30M, an increase of 14.59% to 2022. At the end of 2022 company had $3.75M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Jagsonpal Pharmaceuticals is responsible for during its operational activities.
Jagsonpal Pharmaceuticals (JAGSNPHARM) Total Liabilities History from 2023 to 2022
-
Value:-
JAGSNPHARM Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $4.30M | 14.59% |
| 2022 | $3.75M | -21.21% |
| 2021 | $4.76M | 6.05% |
| 2020 | $4.49M | 87.18% |
| 2019 | $2.40M | - |
View the Top Total Liabilies Stocks
